You are here: Industry Insights > Pfizer

News List

Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata firstwordpharma
August 06, 2021
Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease driven by an immune attack on the hair follicles.
Full Approval of Pfizer COVID-19 Vaccine Could Come in September drugs
August 05, 2021
The U.S. Food and Drug Administration is speeding up its timetable for full approval of the Pfizer coronavirus vaccine, hoping to complete the process by early September.
More than 85 million COVID vaccines administered across the UK, reports DHSC pharmatimes
August 03, 2021
A total of 85,196,986 doses of a COVID-19 vaccine have been administered in the UK according to the latest figures, with 46,851,145 people receiving a first dose (88.6%) and 38,345,841 people receiving both doses (72.5%).
Pfizer and Moderna raise prices for its COVID-19 vaccines in EU firstwordpharma
August 02, 2021
According to the Financial Times, Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest supply contracts with the EU, as reported Sunday in Investing.com.
DHL Express delivers US donation of 1.5m Pfizer-BioNTech Covid-19 vaccine doses to Thailand prnasia
July 30, 2021
DHL Express, the world's leading express service provider today successfully delivered the first batch of 1.5 million Pfizer-BioNTech's Covid-19 vaccine doses donated by the United States government to Thailand.
Pfizer's 2Q Revenues Up 92% contractpharma
July 30, 2021
COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.
Pfizer Says Third Shot of Vaccine Boosts COVID-19 Protection drugs
July 29, 2021
New data show that protection from both doses of the Pfizer COVID-19 vaccine decreases slightly over time but that a third dose significantly boosts levels of antibodies against several variants of the virus, including the highly contagious delta variant.
Data show steady drop-off in protection with Pfizer's COVID-19 vaccine firstwordpharma
July 29, 2021
The effectiveness of Pfizer and partner BioNTech's coronavirus vaccine BNT162b2 steadily declines over time, slipping to roughly 84% for vaccinated people about four to six months after they got their second dose, according to data released Wednesday.
Pfizer, Moderna to Expand Vaccine Studies in Young Children drugs
July 28, 2021
Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation and other rare side effects that occurred in teens and young adults who received the vaccines.
Researchers find extending the time between Pfizer doses boosts antibodies pharmatimes
July 27, 2021
UK researchers have found that extending the time between the first and second doses of the Pfizer/BioNTech COVID-19 vaccine boosted antibodies against all variants of the virus tested compared to a short dosing interval.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page